| |
Company
Roster
|
|
Total
Insiders : |
33 |
|
|
|
Total
Direct Shares :
|
9,720,215 |
|
|
Total
Indirect Shares :
|
9,581,220 |
| |
%
Held by Insiders:
|
19.71% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Mahaffy Patrick J |
Director |
2021-11-19 |
0 |
2019-08-29 |
0 |
| Kwo Elizabeth |
Director |
2021-11-19 |
0 |
2021-06-24 |
0 |
| Levine Mark S. |
General Counsel |
2021-11-19 |
0 |
2018-02-01 |
0 |
| Willwerth Christina |
Chief Strategy Officer |
2021-11-19 |
0 |
2019-03-01 |
0 |
| Muzikant Adam |
Chief Business Officer |
2021-11-19 |
0 |
|
0 |
| Colella Samuel D |
Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
| Canute Scott A |
Director |
2021-11-19 |
0 |
2020-06-10 |
0 |
| Merrifield C Ann |
Director |
2021-11-19 |
0 |
2015-09-11 |
0 |
| Lukatch Heath |
Director |
2021-11-19 |
0 |
2020-06-10 |
0 |
| Clayman Michael D. |
President and CEO, Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
| Stejbach Mark |
Director |
2021-11-19 |
0 |
2020-06-10 |
1,580 |
| Layman Melissa |
Chief Commercial Officer |
2021-11-19 |
0 |
2020-04-01 |
0 |
| Andrews William T. |
Chief Medical Officer |
2021-11-19 |
0 |
2021-08-02 |
0 |
| Driscoll Frederick W |
Chief Financial Officer |
2021-11-19 |
0 |
2014-11-20 |
0 |
| Wentworth Kerry |
Chief Regulatory Officer |
2021-11-19 |
0 |
2021-11-19 |
0 |
| Milinazzo Alan |
Director |
2021-11-19 |
0 |
2020-06-10 |
0 |
| Arkowitz David |
Chief Financial Officer |
2021-05-10 |
220,719 |
2018-06-01 |
0 |
| Kelley Scott |
Chief Medical Officer |
2021-03-01 |
143,549 |
2017-12-20 |
0 |
| Mahatme Sandesh |
Director |
2020-06-10 |
4,500 |
2020-06-10 |
0 |
| Bodick Neil |
Chief Scientific Officer |
2020-01-03 |
100,153 |
2020-01-03 |
389,683 |
| Deniz Yamo |
Chief Medical Officer |
2017-09-05 |
9,000 |
|
0 |
| Praeger Robin L. |
10% Owner |
2016-06-08 |
0 |
2016-06-08 |
409,422 |
| Novo A/s |
10% Owner |
2015-06-22 |
2,133,131 |
2014-02-18 |
0 |
| Sofinnova Partners Sas |
10% Owner |
2014-10-29 |
2,095,491 |
2014-02-18 |
0 |
| Robertson Rebecca B |
10% Owner |
2014-09-10 |
0 |
2016-06-08 |
409,422 |
| Pfizer Inc |
10% Owner |
2014-02-18 |
1,687,250 |
2014-02-18 |
0 |
| Versant Development Fund Iii, L.p. |
Director, 10% Owner |
2014-02-18 |
3,205,001 |
2014-09-10 |
2,250 |
| Tordjman Rafael |
Director, 10% Owner |
2014-02-18 |
0 |
2014-02-18 |
2,105,491 |
| Versant Side Fund Iii, L.p. |
10% Owner |
2014-02-11 |
73,367 |
2014-02-11 |
32,413 |
| Fratamico Arthur |
Officer |
2014-02-11 |
48,054 |
|
0 |
| 5am Co-Investors Ii Lp |
10% Owner |
|
0 |
2014-02-18 |
1,512,076 |
| Schwab Andrew J. |
Director, 10% Owner |
|
0 |
2014-02-18 |
1,512,076 |
| Bolzon Bradley J Phd |
Director, 10% Owner |
|
0 |
2014-02-18 |
3,206,807 |
|
